image
Healthcare - Biotechnology - NASDAQ - US
$ 1.0
-3.85 %
$ 60.6 M
Market Cap
-0.58
P/E
CASH FLOW STATEMENT
-86.2 M OPERATING CASH FLOW
-100.20%
48 M INVESTING CASH FLOW
127.98%
6.93 M FINANCING CASH FLOW
-95.43%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Acumen Pharmaceuticals, Inc.
image
00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)(70m)(70m)(80m)(80m)(90m)(90m)202020202021202120222022202320232024202420252025
Net Income -102 M
Depreciation & Amortization 178 K
Capital Expenditures -16 K
Stock-Based Compensation 9.64 M
Change in Working Capital 11.7 M
Others 2.03 M
Free Cash Flow -86.2 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019
OPERATING CASH FLOW
Net Income (102.3) (52.4) (42.9) (100.6) (7.3) (7.9)
Depreciation & Amortization 0.2 0.2 0.2 4 K 0 0
Deferred Income Tax 0 0 0 0.2 0 0
Stock Based Compensation 9.6 6.1 3.1 0.9 0.2 0.2
Other Operating Activities (5.4) (0.9) 0.5 81.3 (0.6) 0.1
Change in Working Capital 11.7 3.9 4.0 0.3 0.3 0.8
Cash From Operations (86.2) (43.1) (35.2) (18.0) (7.5) (6.8)
INVESTING CASH FLOW
Capital Expenditures 16 K 21 K (0.2) 40 K 0 0
Other Items 48.0 (171.7) 39.3 (104.1) 0 0
Cash From Investing Activities 48.0 (171.7) 39.2 (104.1) 0 0
FINANCING CASH FLOW
Common Stock Repurchased 41 K 0 0 0 0 0
Total Debt Repaid (0.7) 30.0 0 0 0 0
Dividends Paid 0 0 0 0 0 0
Other Financing Activities (0.2) (0.2) 0.1 31.9 44.7 6.2
Cash From Financing Activities 6.9 151.8 3.9 200.5 44.7 6.2
CHANGE IN CASH
Net Change In Cash (31.3) (63.0) 7.9 78.4 37.2 (0.6)
FREE CASH FLOW
Free Cash Flow (86.2) (43.1) (35.3) (18.0) (7.5) (6.8)